Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ramsay Health Care ( (AU:RHC) ) has provided an update.
Ramsay Health Care’s 2025 AGM highlighted the company’s strategic focus on navigating industry challenges, with a renewed emphasis on its core Australian business. Despite facing cost pressures and industry headwinds, the company is optimistic about its refreshed strategy and leadership under new CEO Natalie Davis. Ramsay reported a 1.7% increase in underlying net profit after tax, driven by strong performance in its Australian and UK hospital businesses, although earnings from its UK mental health care business, Elysium, and Ramsay Santé were lower.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$33.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
More about Ramsay Health Care
Ramsay Health Care is a prominent player in the healthcare industry, providing a range of healthcare services across various regions. The company focuses on private healthcare, with a strong emphasis on its Australian hospital business, while also operating in the UK and other regions through entities like Elysium and Ramsay Santé.
YTD Price Performance: -7.31%
Average Trading Volume: 738,953
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.18B
Learn more about RHC stock on TipRanks’ Stock Analysis page.